Company research / ACAD
Acadia Pharmaceuticals Inc (ACAD)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Acadia Pharmaceuticals Inc reported revenue of $1.07B. Revenue grew 11.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.14B.
Key ratios (year ended 2025-12-31)
91.7%
Gross margin (computed)
9.8%
Operating margin
36.5%
Net margin
31.9%
Return on year-end equity
11.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.